Show results for
Refine by
Advanced Heart Failure Suppliers In Usa
7 companies found
based inHouston, TEXAS (USA)
Evaheart, Inc. ('EVI') is a medical device company based in the Texas Medical Center of Houston. EVI was established to gain regulatory approval and commercialize the EVAHEART2 Left Ventricular Assist System in the North American market and start ...
based inMelbourne, AUSTRALIA
Mesoblast is using its proprietary mesenchymal lineage cell technology platform to develop and commercialize innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care. ...
Revascor is a Phase 3 product candidate being developed as a treatment for both advanced and end-stage chronic heart failure ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
based inLisle, ILLINOIS (USA)
Delivering proactive management tools for best practice care and detection of worsening heart failure earlier than ever before. Anthony Nunez, MD, a cardiothoracic surgeon, and Harry Rowland, PhD, a mechanical engineer, met in February 2007. They ...
based in, ARIZONA (USA)
To manage patients with advanced heart failure, every clinician will have the technology awareness and outcome data necessary to confidently consider the TAH as a therapeutic option. At SynCardia Systems, LLC, we have a very special mission: to give ...
based inHouston, TEXAS (USA)
Millar is known as a leader in the innovation of MEMS sensor-enabled devices from mouse to man, enabling medical advancements from heart failure research in mice to providing clinical pressure feedback data through integrated medical devices. With ...
based inSanta Clara, CALIFORNIA (USA)
Ancora Heart is dedicated to providing new treatment options for patients suffering from heart failure. Our team has a deep appreciation for the challenges faced by the estimated 26 million patients across the globe who are living with this chronic, ...